Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,014 public trials 2,030 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan

NCT02272803

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Aomori, Japan
  • Local Institution Chiba, Japan
View all 28 locations
View Trial Details
Completed

"MIRO" Molecularly Oriented Immuno-radio-therapy

NCT02710643

Conditions
Follicular Lymphoma Grade 3A, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, +10 more
Locations
  • Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • Ematologia Azienda Ospedaliera Policlinico Bari, BA, Italy
  • A.O. Spedali Civili Brescia, BS, Italy
  • A.O. Niguarda Milan, MI, Italy
View all 27 locations
View Trial Details
Completed

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

NCT01991184

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +22 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
  • Willamette Valley Cancer Ctr - 520 Country Club Eugene, Oregon, United States
View Trial Details
Completed

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

NCT02063685

Conditions
Follicular Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Sede Di Meldola (Fc) Meldola, Forlì Cesena, Italy
  • ASUR 8 Civitanova Marche, Macerata, Italy
  • Irccs Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Fondazione IRCCS Milano INT Milan, MI, Italy
View all 48 locations
View Trial Details
Completed

A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod

NCT04639115

Conditions
Digestive System Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Orlando Clinical Research Center OCRC Orlando, Florida, United States
  • The Texas Liver Institute San Antonio, Texas, United States
View Trial Details

Related conditions